D. Hansen, P. L. Dendale, M. Beelen, A. Jonkers, A. Mullens and L. Coruy, “Plasma Adipokine and Inflammatory Marker Concentrations Are Altered in Obese, as Opposed to Non-Obese, Type 2 Diabetes Patients,” European Journal of Applied Physiology, Vol. 109, No. 3, 2010, pp. 397-404.
 World Health Organization, “Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report on the Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, Vol. 20, 1997, pp. 1183-1197.
 World Health Organization, “Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow up Report on the Diagnosis of Diabetes Mellitus,” Diabetes Care, Vol. 26, No. 11, 2003, pp. 3160-3167. http://dx.doi.org/10.2337/diacare.26.11.3160
 S. H. Sayolah, M. Miret, J. Sung, C. Varas, D. Gause and F. L. Brancati, “Post Challenge Hyperglycemia and Mortality in a National Sample of U.S Adults,” Diabetes Care, Vol. 24, No. 8, 2001, pp. 1397-1402.
 A. Osibogun, “The Medicine for Poverty: An Argument for Health and Development. The Ninth Sir Samuel Manuwa Lecture,” 36th Annual General and Scientific Meeting, West African College of Physicians (Nigeria Chapter), Uyo, 2012.
 O. O. Ainkugbe, “Non Communicable Disease in Nigeria: National Survey (Final Report) on Hypertension, Coronary Heart Disease, Diabetes Mellitus Hemoglobinopatheis, GGPD Deficiency and Anemia. National Expert Committee on Non-Communicable Disease,” Federal Ministry of Health and Social Services, Lagos, 1997.
 A. A. Motala, T. Esterhrizen and E. Gouwa, “Diabetes and Other Disorders of Glycaemia in a South African Community: Prevalence and Associated Risk Factor,” Diabetes Cares, Vol. 31, No. 9, 2008, pp. 1783-1788.
 K. Rossing, P. K. Christensen, P. Hovind, L. Tarnow, P. Rossing and H. H. Parving, “Progression of Nephropathy in Type 2 Diabetic Patients,” Kidney International, Vol. 66, No. 4, 2004, pp. 1596-1605. http://dx.doi.org/10.1111/j.1523-1755.2004.00925.x
 K. G. Alberti, P. Zimmet and I. Shaw, “International Diabetes Federation: A Consensus on Type 2 Diabetes Prevention,” Diabetes Medicals, Vol. 24, No. 5, 2007, pp. 451-468. http://dx.doi.org/10.1111/j.1464-5491.2007.02157.x
 K. Rossing, P. K. Christensen, P. Hovind, et al., “Progression of Nephropathy in Type 2 Diabetic,” Kidney International, Vol. 66, 2004, pp. 1596-1605. http://dx.doi.org/10.1111/j.1523-1755.2004.00925.x
 J. P. New, I. Aung and P. G. Baker, “The High Prevalence of Unrecognized Anemia in Patients with Diabetes and Chronic Kidney Disease: A Population Based Study,” Diabetes Medicine, Vol. 25, No. 5, 2008, pp. 564-569. http://dx.doi.org/10.1111/j.1464-5491.2008.02424.x
 D. R. Bosman, C. A. Osborn, J. T. Marsden, I. C. Macdougall, W. N. Gardner and P. Watkins, “Erythropoietin Response to Hypoxia in Patients with Diabetic Autonomic Neutropathy and Non Diabetic Chronic Renal Failure,” Diabetic Medical, Vol. 19, No. 1, 2002, pp. 65-69. http://dx.doi.org/10.1046/j.1464-5491.2002.00634.x
 M. Goicoechea, J. Martin, P. De Sequera, J. A. Qunoga, A. Ortiz, V. Carreno and C. Caramelo, “Role of Cytokines in the Response to Erythropoietin in Hemo Dialysis Patients,” Kidney International, Vol. 54, No. 4, 1998, pp. 1337-1343. http://dx.doi.org/10.1046/j.1523-1755.1998.00084.x
 E. O. Zanjani, P. B. McGlave, S. F. Davies, M. Banisadre, M. E. Caplan and G. A. Sarosi, “In Vitro Suppression of Erythropoiesis by Bone Marrow Adherent Cells from Some Patients with Fungal Infection,” British Journal of Hematology, Vol. 50, No. 3, 1998, pp. 479-490.
 D. R. Bosman, A. S. Winkler, J. T. Marsden, I. C. Macdousall and P. J. Watkins, “Anemia with Erythropoietin Deficiency Occurs Early in Diabetic Nephropathy,” Diabetes Care, Vol. 24, No. 3, 2001, pp. 495-499. http://dx.doi.org/10.2337/diacare.24.3.495
 J. C. Kathrine, D. W. Joh, G. R. Stephen, S. Hilary, R. O. David, W. Debbie, C. Ivor and O. P. Aled, “Anemia and Diabetes in the Absence of Nephtropathy,” Diabetes Care, Vol. 28, No. 5, 2005, pp. 1118-1123.